Braidwell »

Argenx Se shares owned by Braidwell

Quarter-by-quarter ownership of Argenx Se (ARGX) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Argenx Se

Tip: Access up to 7 years of quarterly data

All positions including Argenx Se held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Argenx Se by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $58M 153k 380.43
2023-03-31 $9.2M 25k 372.58
2022-12-31 $19M 49k 378.83

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Argenx Se

T. Rowe Price Associates
Artisan Partners Limited Partnership
Henderson Group
venBio Select Advisor
Bellevue Group
Massachusetts Financial Services
Holocene Advisors
Millennium Management
ClearBridge Advisors
Paradigm Biocapital Advisors
Federated Investors
Citadel Advisors
EcoR1 Capital
Bamco
Wellington Management Company

View all funds holding Argenx Se